Amgen (NASDAQ: AMGN) announced today that the U.S. Food and Drug Administration (FDA) has granted full approval to IMDELLTRA® (tarlatamab-dlle) for the treatment of adult patients with extensive stage ...
INTU projects double-digit Q1 revenue growth, fueled by AI integration, platform synergies and strong product momentum.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈